Loading company…
Japanese biopharmaceutical company developing drugs for treating cerebral infarction, with R&D in quasi-drugs and medical equipment.
TMS Co., Ltd. develops drugs for curing cerebral infarction and also conducts research and development of quasi-drugs, pharmaceutical raw materials, medical equipment and medical consumables. Founded in 2005 and based in Japan, the company is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in